Monika Tomaszewska-Kiecana

A first-in-human phase I study of the PD-1 inhibitor, retifanlimab (INCMGA00012), in patients with advanced solid tumors (POD1UM-101)

U. Banerji, J. Powderly, N. Lakhani, 2024, ESMO open.